Policy and Research

Here you will find information out about Ovacome's involvement  in leading change for those affected by ovarian cancer; now and for future generations.

Survey results: 'Have your say on availability of a treatment for patients with platinum resistance'

We explored how chemotherapy impacts patients and to help policymakers understand views on treatment access after platinum resistance.

PICCOS

The PICCOS trial looks at the use of pressurised intraperitioneal aerosolised chemotherapy (PIPAC) in recurrent platinum-resistant ovarian cancer. Ovacome has sat on the  Patient Advisory Group for the last two years.

Menopause guidelines update

Ovacome's Head of Support represented your perspectives on menopause.

Read about the impact this had.

Can your shopping receipt predict ovarian cancer?

Find out how data from our shopping habits can indicate undiagnosed health issues.

Patient voices change guidance for GCT monitoring

Find out how patient-led research contributed to new findings and changes to Granulosa Cell Tumour monitoring.

The GRACEFUL study

This study looks into the most important aspects of location of care for patients with gynaecological cancers.

Read more and find out how to particpate.

All-Part Parliamentary Group on Women’s Health position paper (APPG)

Ovacome is pleased to have contributed to the APPG on Women’s Health position paper on ovarian cancer, amplifying your voices and calling for change.

Chemotherapy-induced Peripheral Neuropathy Preventative (CIPN) Device Workshop

This study looks at designing a medical device with and for people with CIPN. Find out how to participate.



Do you have a research project that you would like Ovacome's help with?
Ovacome may be able to help with research projects that meet certain requirements. To find out more and make and enquiry, please click below.

Find out more and enquire

Become part of the Ovacome community

Our members are at the heart of everything we do. There’s no cost to membership. Be the first to hear about Ovacome news and join a friendly, supportive community, all working together to promote knowledge and support others.